Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has submitted to the exchanges a copy of a newspaper notice published on 7th May 2025 in Indian Express (English) and Financial Express (Gujarati edition). The notice informs shareholders that their equity shares are liable to be transferred to the Investor Education and Protection Fund (IEPF) Demat Account, as the dividend on these shares has not been paid or claimed for seven or more consecutive years. The company has individually contacted the concerned shareholders and uploaded the list of affected shareholders on its website (alembicpharmaceuticals.com/iepf). Shareholders must act by 10th August 2025, after which the shares will be transferred to the IEPF Demat Account. Shareholders can recover shares and unclaimed dividends later by filing IEPF Form 5 with the IEPF Authority.
This is a routine regulatory compliance filing with no direct impact on the company's financials or stock price. However, shareholders with unclaimed dividends for 7+ years risk losing their shares to the IEPF if they do not respond by 10th August 2025.